Phosphagenics is a Melbourne-based, globally driven biotechnology company focused on the discovery of new and cost effective ways to enhance the delivery of proven pharmaceutical and nutraceutical products. 

Phosphagenics’ core technology is built around the science and application of TPM® delivery systems.  This unique system enables transdermal delivery of proven pharmaceutical actives and enhances dermal delivery of pharmaceutical, cosmeceutical and nutraceutical actives.  The technology also improves the oral bioavailability of nutritional actives, such as vitamins.

Phosphagenics' shares are listed on the Australian Stock Exchange (POH).  Phosphagenics' ADR's (PPGNY) are traded on the OTCQX in the USA.


 (ASX : POH)